Bispebjerg Hospital — Clinical Trial Site

41 Registered trials

13 Currently recruiting

Organisation

Bispebjerg Hospital

Location

Copenhagen Nv, Denmark

Identifier

ORG-100028742

Address

Ebba Lunds Vej 44, 2400, Denmark

Departments

#7112
2001: Department of Anaesthesia and Intensive Care
Abdominalcenter K
Abdominalcenter K, Bispebjerg Hospital
Afdeling for Lunge- og infektionssygdomme
Anaesthesia
Anaesthesia and Intensive Care
Bispebjerg and Frederiksberg Hospital, Department of Cardiology
Cardiology
Cardiology, Y
Copenhagen Diabetes Foot Center, Department of Endocrinology, University of Copenhagen
Department of Anesthesiology and Intensive Care
Department of Cardiology
Department of Cardiology Y
Department of Dermatology
Department of Lung Medicine L
Department of Neurology
Department of Respiratory Medicine
Dept. of Anaesthesia and Intensive Care, Bispebjerg Hospital, Copenhagen University Hospital
Dermato-Venerologisk Afdeling
Dermatology
Digestive Disease Center
Endocrinology
Endokrinologisk afd.
Forskningsenhed K, Abdominalcenter K
Lungemedicinsk Forskningsafdeling
Lungemedicinsk forskningsenhed
N/A
Neurologisk afd. Nielsine Nielsensvej 11.a
Neurology
Pulmonary Diseases
Pulmonology and Infectious diseases
The Parker Institute

Clinical trials at this site (41)

Search interface

Boosting recovery through excitation of arousal and awareness in comatose patients (BREA2KTHROUGH) Not authorised

2023-503617-30-01 Coma and other disorders of consciousness due to acute 9
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA). Recruiting

2023-507031-38-00 Severe viral lung infections 5 2023-01-09
Boosting recovery through excitation of arousal and awareness in comatose patients: Dose finding study (BREA2KTHROUGH DOSEFINDER) Recruiting

2023-503617-30-02 Coma and other disorders of consciousness due to acute 3 2025-02-26
Colchicine for ischemia with no obstructive coronary artery disease and microvascular dysfunction Recruiting

2023-507981-17-00 CMD 4 2024-11-20
New treatments to reduce cardiovascular disease in type 1 diabetes Recruiting

2023-505794-32-04 Type 1 diabetes 5 2024-07-05
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting

2023-507617-96-01 Pyogenic vertebral osteomyelitis 6 2024-02-14
The OPTIMIST study Recruiting

2023-505940-20-00 osteoporosis 11 2023-09-26
VASODILATATION OR LOOP-DIURETICS FOR INITIAL TREATMENT OF PULMONARY CONGESTION DUE TO ACUTE HEART FAILURE – A RANDOMIZED PLACEBO-CONTROLLED … Recruiting

2022-500035-36-01 Acute heart failure with pulmonary congestion 6 2023-09-14
Infliximab for non-Crohn Anal Fistulas Recruiting

2022-502263-38-00 Anal fistula 4 2023-09-01
Acute Subcutaneous Semaglutide in Acute Ischemic Stroke (ASSET Trial) Recruiting

2022-501072-25-02 Ischemic Stroke 4 2023-04-12
Immunotherapy in patients with early dMMR rectal cancer. A Danish DCCG phase II trial Recruiting

2022-500646-14-00 cancer 4 2023-01-31
CROWD-ASPECT Recruiting

2022-502239-20-00 Heart failure 6 2023-01-01
Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) Recruiting

2023-508105-24-00 COVID-19 5 2021-11-11
Metformin treatment of patients with hand osteoarthritis: A randomised, placebo-controlled trial Ended

2023-509181-38-00 Osteoarthritis 5 2024-05-03
A clinical trial to assess the safety and effects of AGMB-129 compared to placebo in patients with fibrostenotic Crohn’s disease. Ended

2022-502789-26-01 Fibrostenotic Crohn’s Disease 4 2023-11-03
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation. Ended

2022-501939-16-00 Heart failure (HF) with mildly reduced ejection fractio 5 2023-05-09
Safety of ibuprofen after major orthopaedic surgeries Ended

2022-502502-32-00 Hip and knee arthroplasties 11 2023-04-17
DANNOAC- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study Ended

2022-501912-32-00 Atrial Fibrillation (and atrial flutter), deep vein tro 6 2023-04-01
Bicarbonate for the treatment of cardiac arrest Ended

2022-501304-10-00 In-hospital cardiac arrest 6 2023-02-06